SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

OMXC 20 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Genmab: Click to view the issuer\'s details

Last update : 25/05/2014  >View issuer details

2019.01.08 | 18:34 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Achieves USD 75 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen - HTML (w)

2019.01.03 | 14:48 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab to Present at the 37th Annual J.P. Morgan Healthcare Conference - HTML (w)

2018.12.20 | 11:26 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces European Commission Approval of DARZALEX® (daratumumab) Split Dosing Regimen - HTML (w)

2018.12.03 | 08:17 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab to Hold R&D Update and 2018 ASH Data Review Meeting - HTML (w)

2018.11.26 | 14:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab to Hold R&D Update and 2018 ASH Data Review Meeting - HTML (w)

2018.11.20 | 18:20 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Capital Increase in Genmab as a Result of Employee Warrant Exercise - HTML (w)

2018.11.19 | 13:21 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce CHMP Issues Positive Opinion on Split Dosing Regimen for DARZALEX® (daratumumab) - HTML (w)

2018.11.14 | 17:00 | Permanent Information Releases / Sales and Revenues

English version HTML (w) Mail

puce Genmab Announces Financial Results for the First Nine Months of 2018 - HTML (w)

2018.11.14 | Periodic information / 3rd Quarter Information

English version PDF Mail

puce Genmab : First Nine Months of 2018 - PDF (601Kb)

2018.11.08 | 14:57 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab to Present at the Jefferies 2018 London Healthcare Conference - HTML (w)

2018.11.01 | 14:16 | Annual General Meeting / Preparatory Documents

English version HTML (w) Mail

puce Genmab Announces Data to be Presented at 2018 ASH Annual Meeting - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 / Doc nb : 69